Treatment of Colonic Obstruction With Cook Evolution® Colonic Stent System

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The objective of this registry is to compile clinical data on the use of the Evolution® Colonic Stent System for the palliative treatment of colonic obstruction or strictures caused by malignant neoplasms and to relieve acute large bowel obstruction prior to colectomy in patients with malignant strictures.

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT01997684` - Colonic Stenting With Elective Surgery Versus Emergency Surgery in the Management of Acute Malignant Colonic Obstruction	N/A

NCT number	NCT01102283
Study type	Observational
Source	Cook
Contact
Status	Completed
Phase	N/A
Start date	April 2010
Completion date	February 2012

Treatment of Colonic Obstruction With Cook Evolution® Colonic Stent System

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms